These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23408116)
21. UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables. Navarro SL; Chen Y; Li L; Li SS; Chang JL; Schwarz Y; King IB; Potter JD; Bigler J; Lampe JW Drug Metab Dispos; 2011 Sep; 39(9):1650-7. PubMed ID: 21666065 [TBL] [Abstract][Full Text] [Related]
22. Human UDP-glucuronosyltransferase 1A1 is the primary enzyme responsible for the N-glucuronidation of N-hydroxy-PhIP in vitro. Malfatti MA; Felton JS Chem Res Toxicol; 2004 Aug; 17(8):1137-44. PubMed ID: 15310245 [TBL] [Abstract][Full Text] [Related]
23. Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. Strassburg CP; Manns MP; Tukey RH J Biol Chem; 1998 Apr; 273(15):8719-26. PubMed ID: 9535849 [TBL] [Abstract][Full Text] [Related]
24. Coexpression of Human Hepatic Uridine Diphosphate Glucuronosyltransferase Proteins: Implications for Ontogenetic Mechanisms and Isoform Coregulation. Liu Y; Badée J; Takahashi RH; Schmidt S; Parrott N; Fowler S; Mackenzie PI; Coughtrie MWH; Collier AC J Clin Pharmacol; 2020 Jun; 60(6):722-733. PubMed ID: 31879975 [TBL] [Abstract][Full Text] [Related]
25. Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Girard H; Lévesque E; Bellemare J; Journault K; Caillier B; Guillemette C Pharmacogenet Genomics; 2007 Dec; 17(12):1077-89. PubMed ID: 18004212 [TBL] [Abstract][Full Text] [Related]
26. Racial variability in haplotype frequencies of UGT1A1 and glucuronidation activity of a novel single nucleotide polymorphism 686C> T (P229L) found in an African-American. Kaniwa N; Kurose K; Jinno H; Tanaka-Kagawa T; Saito Y; Saeki M; Sawada J; Tohkin M; Hasegawa R Drug Metab Dispos; 2005 Mar; 33(3):458-65. PubMed ID: 15572581 [TBL] [Abstract][Full Text] [Related]
27. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone. Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544 [TBL] [Abstract][Full Text] [Related]
28. Acetaminophen UDP-glucuronosyltransferase in ferrets: species and gender differences, and sequence analysis of ferret UGT1A6. Court MH J Vet Pharmacol Ther; 2001 Dec; 24(6):415-22. PubMed ID: 11903872 [TBL] [Abstract][Full Text] [Related]
29. Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p. Dluzen DF; Sun D; Salzberg AC; Jones N; Bushey RT; Robertson GP; Lazarus P J Pharmacol Exp Ther; 2014 Mar; 348(3):465-77. PubMed ID: 24399855 [TBL] [Abstract][Full Text] [Related]
30. Association analysis of UGT1A genotype and haplotype with SN-38 glucuronidation in human livers. Wang H; Bian T; Jin T; Chen Y; Lin A; Chen C Pharmacogenomics; 2014 Apr; 15(6):785-98. PubMed ID: 24897286 [TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of human UDP-glucuronosyltransferase genes. Hu DG; Meech R; McKinnon RA; Mackenzie PI Drug Metab Rev; 2014 Nov; 46(4):421-58. PubMed ID: 25336387 [TBL] [Abstract][Full Text] [Related]
32. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635 [TBL] [Abstract][Full Text] [Related]
33. UGT1A polymorphisms in a Swedish cohort and a human diversity panel, and the relation to bilirubin plasma levels in males and females. Mercke Odeberg J; Andrade J; Holmberg K; Hoglund P; Malmqvist U; Odeberg J Eur J Clin Pharmacol; 2006 Oct; 62(10):829-37. PubMed ID: 16909274 [TBL] [Abstract][Full Text] [Related]
34. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank. Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the Ontogeny of Hepatic UDP-Glucuronosyltransferase Enzymes Based on Glucuronidation Activity Measured in Human Liver Microsomes. Badée J; Qiu N; Collier AC; Takahashi RH; Forrest WF; Parrott N; Schmidt S; Fowler S J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S42-S55. PubMed ID: 31502688 [TBL] [Abstract][Full Text] [Related]
36. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities. Rowland A; Knights KM; Mackenzie PI; Miners JO Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158 [TBL] [Abstract][Full Text] [Related]
37. Hepatic glucuronidation of 4-tert-octylphenol in humans: inter-individual variability and responsible UDP-glucuronosyltransferase isoforms. Isobe T; Ohkawara S; Tanaka-Kagawa T; Jinno H; Hanioka N Arch Toxicol; 2017 Nov; 91(11):3543-3550. PubMed ID: 28500425 [TBL] [Abstract][Full Text] [Related]
38. UDP-glucuronosyltransferase (UGT) 1A1 mainly contributes to the glucuronidation of trovafloxacin. Fujiwara R; Sumida K; Kutsuno Y; Sakamoto M; Itoh T Drug Metab Pharmacokinet; 2015 Feb; 30(1):82-8. PubMed ID: 25760534 [TBL] [Abstract][Full Text] [Related]
39. Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines. Bellemare J; Rouleau M; Harvey M; Têtu B; Guillemette C Pharmacogenomics J; 2010 Oct; 10(5):431-41. PubMed ID: 19997083 [TBL] [Abstract][Full Text] [Related]
40. Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4'-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes. Nakajima M; Sakata N; Ohashi N; Kume T; Yokoi T Drug Metab Dispos; 2002 Nov; 30(11):1250-6. PubMed ID: 12386132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]